Colgate-Palmolive FY2025 revenue +1.4% to $20.4B; GAAP EPS $2.63, down 25% on impairment

COLGATE PALMOLIVE CO

2025-FY EPS reported $2.63 vs consensus $0.94 ▲ beat (+179.9%)

Full year net sales $20,382M (+1.4%); organic sales growth +1.4% after -0.7% impact from lower private label pet volume.
GAAP diluted EPS $2.63, down 25% YoY due to goodwill/intangibles impairment in skin health business.
Base Business EPS $3.69, up 3% YoY; record net cash from operations $4,198M.
Returned $2.9B to shareholders via dividends and share repurchases in FY2025.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.